oral

Anavex Life Sciences Reports Sustained Long-Term Benefits of Oral Blarcamesine in Early Alzheimer’s Disease Over Nearly Three Years

Copenhagen, Denmark – Anavex Life Sciences, a biopharmaceutical company focused on central nervous system disorders, has announced that the therapeutic…